SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-24-001744
Filing Date
2024-04-08
Accepted
2024-04-08 16:10:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 greatpoint-otlk040124.htm SC 13G 118138
  Complete submission text file 0001172661-24-001744.txt   119837
Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-89495 | Film No.: 24829680
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)